HTLV-1 INFECTION
Clinical trials for HTLV-1 INFECTION explained in plain language.
Never miss a new study
Get alerted when new HTLV-1 INFECTION trials appear
Sign up with your email to follow new studies for HTLV-1 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new combo for Tough-to-Treat blood cancer
Disease control TerminatedThis early-stage study aims to find the safest and most effective dose of the drug lenalidomide when given alongside a standard chemotherapy regimen (called EPOCH) for adult T-cell leukemia/lymphoma (ATLL), a rare and aggressive cancer. It will involve about 30 adults with ATLL t…
Matched conditions: HTLV-1 INFECTION
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Researchers track survival in rare virus-linked cancers
Knowledge-focused OngoingThis study follows patients infected with HTLV-1 virus to understand their long-term survival. It tracks two groups: those who develop a serious blood cancer (ATL) and those who don't. Researchers will collect detailed medical information over time to learn how the disease progre…
Matched conditions: HTLV-1 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC